Fisher & Paykel Healthcare : Annual Shareholders’ Meeting Results, Director Announcements and Director Independence
August 24, 2017 at 12:53 am EDT
Share
Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company's annual shareholders' meeting held in Auckland today were passed. The seven resolutions were:
Resolution 1: To re-elect Tony Carter as a Director.
Resolution 2: To re-elect Geraldine McBride as a Director.
Resolution 3: To elect Pip Greenwood as a Director.
Resolution 4: To approve the remuneration of Directors.
Resolution 5: To authorise the Directors to fix the fees and expenses of the Company's auditor.
Resolution 6: To approve the issue of share rights to Lewis Gradon as set out in the Notice of Annual Shareholders' Meeting 2017.
Resolution 7: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders' Meeting 2017.
All resolutions were decided by poll. The details of the total number of votes cast in person or by proxy on the polls were as follows:
Resolution
Votes For
%
Votes Against
Total Votes Cast
Abstain
Resolution 1 Re-election of
Tony Carter
351,603,320
98.21
6,403,875
358,007,195
396,170
Resolution 2: Re-election of Geraldine McBride
357,781,249
99.90
351,434
358,132,683
270,682
Resolution 3: Election of Pip Greenwood
357,673,616
99.90
363,872
358,037,488
365,877
Resolution 4: Approval of remuneration of Directors
354,277,494
99.68
1,132,929
355,410,423
611,423
Resolution 5: Authorise Directors to fix fees and expenses of auditor
357,954,772
99.94
223,507
358,178,279
225,086
Resolution 6: Issue of share rights to Lewis Gradon
338,138,936
93.98
21,646,301
359,785,237
526,130
Resolution 7: Issue of options to Lewis Gradon
338,122,803
93.98
21,643,771
359,766,574
544,793
Independence of Directors
In accordance with NZX Listing Rule 3.3.3(a), the Board has determined that Tony Carter, Pip Greenwood, Geraldine McBride, Arthur Morris, Donal O'Dwyer and Scott St John are independent directors.
The factors that the Board considers in assessing the independence of directors are set out in the Board Charter, which can be viewed on the company's website: www.fphcare.com/corporategovernance.
Contact: Ed Timmins, Company Secretary on +64 9 574 0164. For more information about the company visit our website www.fphcare.com
Fisher & Paykel Healthcare Corporation Ltd. published this content on 24 August 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 24 August 2017 04:52:12 UTC.
Original documenthttps://www.fphcare.co.nz/our-company/investor/investor-news/annual-shareholders-meeting-results-director-ann/
Public permalinkhttp://www.publicnow.com/view/62DB2B5D24CA9E1F3F394BEC85057BD173ECD6CE
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Companyâs products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.